REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
Regenxbio Inc. (RGNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 3,760,690 | $67,504,386 | +47% | 2.41% |
| 2. | Aquilo Capital Management Marc Schneidman | 802,424 | $14,403,511 | -6% | 8.97% |
| 3. | BioImpact Capital Mpm Capital | 549,078 | $9,855,950 | -17% | 2.3% |
| 4. | Water Street Capital Gilchrist Berg | 431,200 | $7,740,040 | -31% | 0.45% |
| 5. | Perceptive Advisors Joseph Edelman | 342,408 | $6,146,224 | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.00 | 49,000 | Large Shareholder, Other | 49,000 | 2015-09-22 | Filing | |
| $22.00 | 38,500 | Large Shareholder, Other | 38,500 | 2015-09-22 | Filing | |
| $22.00 | 87,500 | Large Shareholder, Other | 1,256,542 | 2015-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.19 | 15,000 | 408,035 | 2024-04-15 | Filing | ||
| $21.86 | 15,000 | 408,035 | 2024-03-14 | Filing | ||
| $28.36 | 12,878 | 107,192 | 2024-03-05 | Filing | ||
| $16.88 | 10,348 | 408,035 | 2024-02-14 | Filing | ||
| $16.47 | 4,652 | 418,383 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,207,548 | $147,325,487 | 0% | |
| 2. | 4,440,838 | $79,713,043 | 0% | |
| 3. | 3,939,549 | $70,714,905 | 0% | |
| 4. | 2,631,220 | $47,230,399 | 0% | |
| 5. | 1,820,382 | $32,675,865 | 0% |
News See All
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the REGENXBIO Inc. First Quarter 2023 Conference Call. Please be advised that today's conference is being recorded.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
11 Cheap Healthcare Stocks To Invest In
Healthcare is one of the biggest sectors in the world. According to a research report, the healthcare consumer market size was $332.391 billion and is expected to reach $667.37 billion by 2028.
Top 5 Stock Picks of Lawrence Kam's Sonic Capital
In this article, we will take a look at the top 5 stock picks of Lawrence Kam's Sonic Capital.
5 Best Biotech Stocks to Buy According to Alan Frazier
In this article, we discuss the 5 best dividend stocks to buy according to Alan Frazier.
Where Do Hedge Funds Stand On Regenxbio Inc (RGNX)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is RGNX A Good Stock To Buy According To Hedge Funds?
In this article you are going to find out whether hedge funds think Regenxbio Inc (NASDAQ:RGNX) is a good investment right now.
Billionaire Hedge Funds
